Total Results: 7183
Chief Executive Heather Bresch will testify in front of the House Oversight and Government Reform Committee next week. Meanwhile, senators will introduce a bill requiring drugmakers to give a 30-day notice and justification of any prescription drug price increase of more than 10 percent. And The Associated Press examines pharmaceutical discount cards.
The Kaiser Family Foundation analysis finds that premiums for health insurance family plans offered through a workplace grew about 3 percent. Yet that was partly the result of employers shifting costs to workers through increased deductibles, which have grown nearly six times as fast as wages.
The top five managers took home almost $300 million over the past five years, The Wall Street Journal reports amid continuing questions about the manufacter’s EpiPen pricing. News outlets also report on an FDA warning to doctors about drug risks, the pros and cons of pharmaceutical ads and a drop in the cost of generics.
If the bill is signed, patients who go to a covered facility would only be charged in-network fees, no matter who treats them.
Researchers at the University of California, San Francisco estimate that hospitals could lose nearly $1,000 per surgery by throwing away opened but unused supplies, such as gloves and sponges.
State Sen. Ed Hernandez’s drug pricing transparency bill faltered, but that hasn’t stopped him from introducing a measure to urge Congress to investigate EpiPen maker Mylan.
The California measure would protect consumers and provide better reimbursement for care, supporters say.
Department of Health and Human Services researchers compared counties across state borders and adjusted for several differences between them. Their calculations led them to conclude that expanding Medicaid helped produce to marketplace premiums that were 7 percent lower.
The Wall Street Journal reports that the burden of health care costs is shifting in greater part to working middle-class families, in large part because of higher deductibles in insurance plans.
A Sonoma Country family feels the pinch of the high price of this emergency allergy medicine. Meanwhile, news outlets explore recent developments such as the response by Mylan, the company that markets the EpiPen, as well as positions being taken by lawmakers, parents, public figures and even Mylan’s CEO.